Notably, CHRDL2 has been reported to promote the proliferation and metastasis of osteosarcoma cells through the BMP‐9/PI3K/Akt signaling pathway; by binding with BMP‐9, CHRDL2 decreased BMP‐9 expression [31]. Here, AKT1 is linked to osteosarcoma.